NASDAQ:BPMC - Blueprint Medicines Price Target & Analyst Ratings

-0.06 (-0.08 %)
(As of 09/15/2019 04:00 PM ET)
Today's Range
Now: $78.94
50-Day Range
MA: $84.38
52-Week Range
Now: $78.94
Volume332,512 shs
Average Volume458,480 shs
Market Capitalization$3.88 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Blueprint Medicines (NASDAQ:BPMC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Blueprint Medicines in the last 12 months. Their average twelve-month price target is $109.1111, suggesting that the stock has a possible upside of 38.22%. The high price target for BPMC is $125.00 and the low price target for BPMC is $85.00. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.912.903.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $109.1111$112.1250$109.40$103.25
Price Target Upside: 38.22% upside34.09% upside15.88% upside31.18% upside

Blueprint Medicines (NASDAQ:BPMC) Consensus Price Target History

Blueprint Medicines (NASDAQ:BPMC) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/12/2019Raymond JamesUpgradeMarket Perform ➝ OutperformLow
9/9/2019Piper Jaffray CompaniesReiterated RatingHoldLow
9/9/2019CowenReiterated RatingBuyHigh
8/2/2019Canaccord GenuityBoost Price TargetBuy$105.00 ➝ $120.00High
7/18/2019Robert W. BairdInitiated CoverageOutperform$120.00Medium
7/18/2019Deutsche BankInitiated CoverageBuy ➝ Buy$110.00Medium
5/23/2019Goldman Sachs GroupReiterated RatingBuy ➝ Buy$125.00High
4/3/2019Morgan StanleyInitiated CoverageOverweight$112.00Low
2/26/2019WedbushReiterated RatingOutperformHigh
9/25/2018Leerink SwannInitiated CoverageOutperform ➝ Outperform$105.00Medium
9/18/2018GuggenheimInitiated CoverageBuy$102.00High
6/4/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Buy$109.00 ➝ $103.00High
9/29/2017DA DavidsonInitiated CoverageBuy$90.00High
9/29/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$90.00High
(Data available from 9/15/2017 forward)
This page was last updated on 9/15/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel